GCBRO 100
Acebrophylline 100 mg Capsules
In the treatment of chronic obstructive pulmonary disease (COPD) new generation airway mucus regulator
- An airway mucoregulator and anti-inflammatory agent
- Selective reaction to bronchus and alveolus by regiospecific targeting technology
- No side effects induced by xanthine type antitussive
- Significant improvement in lung function
- Reduces the use of short acting beta-2 agonist inhalers
In
- Acebrophylline is an airway mucus regulator with
- anti-inflammatory action
- Reduction in specific bronchial hyper-responsiveness
- in patients with stable bronchial asthma
Take control of ASTHMA SYMPTOMS